spacer
home > events calendar
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR
   
  
EVENTS FOR 2018
   
 
EVENTS FOR ALL MAGAZINES
 
     

Pharma and Device Packaging and Labelling West Coast 2018

27-28 November 2018
Burlingame, CA

The second edition of the Pharma and Device Packaging and Labeling West Coast was a thought-provoking two days of engaging presentations, discussion and networking. More>>

 
 

Partnerships in Clinical Trials Europe 2018

27-29 November 2018
CCIB, Barcelona

Partnerships in Clinical Trials Europe is back – and bigger than ever. Europe’s most complete clinical meeting is bringing together 1000+ of the industry’s leading experts this November for it’s 17th annual gathering, and you’re invited! More>>

 
phone +44 (0)20 3377 3279
email LS.Registrations@Knect365.com
web lifesciences.knect365.com/pct-europe/
email CCIB, Barcelona
 

RDD Asia 2018

14-15 November 2018
Grand Hyatt Kochi, Kerala, India

A must-attend meeting for pulmonary and nasal researchers, inhaled product developers and vendors active in this important pharmaceutical niche. More>>

 
phone tel:+01-804-827-1490
email rddasia@rddonline.com
web www.rddonline.com/rddasia2018
email RDD Asia 2018, Grand Hyatt Kochi, Kerala, India
 

10th Annual NGS & Clinical Diagnostics Congress

8-9 November 2018
London, UK

Oxford Global is proud to present its 10thAnnual NGS & Clinical Diagnostics Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies. More>>

 
phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2jYBa44
email London
 

6th Annual Single Cell Analysis Congress

8-9 November 2018
London, UK

Oxford Global is proud to present its 6th Annual Single Cell Analysis Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies. More>>

 
phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2wJJRsc
email London
 

Synthetic Biology Congress

8-9 November 2018
London, UK

Oxford Global is proud to present its Synthetic Biology Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies. More>>

 
phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2MtRRQY
email London
 

4th Annual Genome Editing Congress

8-9 November 2018
London, UK

Oxford Global is proud to present its 4thAnnual Genome Editing Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies. More>>

 
phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2tHrM9q
email London
 

BIO-Europe 2018-24th Annual International Partnering Conference

5-7 November 2018
Bella Center Copenhagen, Denmark

The 24th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. More>>

 
phone +49 89 2388 756-25
email cmoreno@ebdgroup.com
web bit.ly/2Mres56
email Bella Center Copenhagen, Denmark
 

SAPHEX 2018

1-2 November 2018
Gallagher Convention Centre, Midrand, South Africa

The SAPHEX exhibition and conference is now established as the “go-to” networking and business event for anyone working in the South African pharmaceutical manufacturing industry. More>>

 
phone 0044 (0) 203 198 9621
email jessica@saphex.co.za
web www.saphex.co.za
email Gallagher Convention Centre, Midrand, South Africa
 
spacer
Industry Events

Pharma and Device Packaging and Labelling West Coast 2018

27-28 November 2018, Burlingame, CA

The second edition of the Pharma and Device Packaging and Labeling West Coast was a thought-provoking two days of engaging presentations, discussion and networking.
More info >>

Banner of DIA_Europe_Events_95 on Samedan Banner of Drug Delivery Partnership 2018_events_97 on Samedan Banner of PHPL West Coast_events_95 on Samedan

White Papers

Soothing the Logistical Headache of Clinical Trials

Equilibrium Travel Management

As many as 30 per cent of subjects on phase three clinical studies drop out.  Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial.  It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >>


News and Press Releases

Clinical and Regulatory Operational Excellence Forum

1. Innovative technologies are expected to take clinical development, licensing, and other regulatory processes to the next level in the future. What do you see are the biggest challenges facing companies when trying to cope with continued data growth in a fast changing environment? Pharmaceutical companies are heavily regulated and introducing change needs proof of acceptance by the authorities. The chance that authorities do not agree with that change makes the industry risk averse. Changes in a stable GxP environment are almost by default seen as a risk, however, not adapting to new technologies should also be seen as a risk! Therefore, ICH developed the ICH Q8, Q9, Q10, Q11, and Q12 guidelines, to anticipate change and implement changes much faster, with less of a regulatory burden. Nevertheless, industry is not picking up with the desired pace. Why not?
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement